145 related articles for article (PubMed ID: 37654466)
1. Synthesis, characterization, and antiparasitic effects of zinc oxide nanoparticles-eugenol nanosuspension against
Cheraghipour K; Khudair Khalaf A; Moradpour K; Zivdari M; Beiranvand M; Shakib P; Mahmoudvand H; Marzban A
Heliyon; 2023 Aug; 9(8):e19295. PubMed ID: 37654466
[TBL] [Abstract][Full Text] [Related]
2. Zinc oxide nanoparticles produced by Zingiber officinale ameliorates acute toxoplasmosis-induced pathological and biochemical alterations and reduced parasite burden in mice model.
El-Kady AM; S Hassan A; Mohamed K; Alfaifi MS; Elshazly H; Alamri ZZ; Wakid MH; Gattan HS; Altwaim SA; Al-Megrin WAI; Younis S
PLoS Negl Trop Dis; 2023 Jul; 17(7):e0011447. PubMed ID: 37410712
[TBL] [Abstract][Full Text] [Related]
3. The Therapeutic Efficacy of Zinc Oxide Nanoparticles on Acute Toxoplasmosis in BALB/c Mice.
Siahkal KR; Keshavarz H; Shojaee S; Mohebali M; Zeraati H; Azami SJ; Behkar A; Salimi M
Iran J Parasitol; 2023; 18(4):505-513. PubMed ID: 38169550
[TBL] [Abstract][Full Text] [Related]
4. Zinc Oxide and Magnesium-Doped Zinc Oxide Nanoparticles Ameliorate Murine Chronic Toxoplasmosis.
Sarhan MH; Felemban SG; Alelwani W; Sharaf HM; Abd El-Latif YA; Elgazzar E; Kandil AM; Tellez-Isaias G; Mohamed AA
Pharmaceuticals (Basel); 2024 Jan; 17(1):. PubMed ID: 38256946
[No Abstract] [Full Text] [Related]
5. Preparation of Zinc Oxide Nanoparticles Assisted by Okra Mucilage and Evaluation of its Biological Activities.
Shakib P; Mirzaei SZ; Lashgarian HE; Saki R; Goudarzi G; Alsallameh S; Marzban A; Cheraghipour K
Curr Drug Discov Technol; 2023; 20(2):e011222211472. PubMed ID: 36464868
[TBL] [Abstract][Full Text] [Related]
6. Acaricidal, pediculocidal and larvicidal activity of synthesized ZnO nanoparticles using wet chemical route against blood feeding parasites.
Kirthi AV; Rahuman AA; Rajakumar G; Marimuthu S; Santhoshkumar T; Jayaseelan C; Velayutham K
Parasitol Res; 2011 Aug; 109(2):461-72. PubMed ID: 21340566
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of acute experimental toxoplasmosis by spiramycin-loaded chitosan nanoparticles.
Hagras NA; Allam AF; Farag HF; Osman MM; Shalaby TI; Fawzy Hussein Mogahed NM; Tolba MM; Shehab AY
Exp Parasitol; 2019 Sep; 204():107717. PubMed ID: 31228418
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of scolicidal potential of salicylate coated zinc nanoparticles against Echinococcus granulosus protoscoleces.
Cheraghipour K; Azarhazine M; Zivdari M; Beiranvand M; Shakib P; Rashidipour M; Mardanshah O; Mohaghegh MA; Marzban A
Exp Parasitol; 2023 Mar; 246():108456. PubMed ID: 36610471
[TBL] [Abstract][Full Text] [Related]
9. Comparative study between zinc oxide nanoparticles synthesis by biogenic and wet chemical methods in vivo and in vitro against Staphylococcus aureus.
Hamouda RA; Yousuf WE; Mohammed ABA; Mohammed RS; Darwish DB; Abdeen EE
Microb Pathog; 2020 Oct; 147():104384. PubMed ID: 32679246
[TBL] [Abstract][Full Text] [Related]
10. Antiparasitic effects of oxymatrine and matrine against Toxoplasma gondii in vitro and in vivo.
Zhang X; Jin L; Cui Z; Zhang C; Wu X; Park H; Quan H; Jin C
Exp Parasitol; 2016 Jun; 165():95-102. PubMed ID: 26993085
[TBL] [Abstract][Full Text] [Related]
11. Mycogenic Synthesis of Extracellular Zinc Oxide Nanoparticles from
Sumanth B; Lakshmeesha TR; Ansari MA; Alzohairy MA; Udayashankar AC; Shobha B; Niranjana SR; Srinivas C; Almatroudi A
Int J Nanomedicine; 2020; 15():8519-8536. PubMed ID: 33173290
[TBL] [Abstract][Full Text] [Related]
12. Quantification and Brain Targeting of Eugenol-Loaded Surface Modified Nanoparticles Through Intranasal Route in the Treatment of Cerebral Ischemia.
Ahmad N; Ahmad R; Alam MA; Ahmad FJ
Drug Res (Stuttg); 2018 Oct; 68(10):584-595. PubMed ID: 29669380
[TBL] [Abstract][Full Text] [Related]
13. Green synthesised zinc oxide nanoparticles reveal potent in vivo and in vitro antibacterial efficacy against Proteus mirabilis isolates.
Elekhnawy E; Almurshedi AS; Abdelkader DH; El-Masry TA; Aldosari BN; El-Bouseary MM; Donia AA; Negm WA
Int J Pharm; 2023 Jul; 642():123111. PubMed ID: 37302668
[TBL] [Abstract][Full Text] [Related]
14. Desertifilum sp. EAZ03 cell extract as a novel natural source for the biosynthesis of zinc oxide nanoparticles and antibacterial, anticancer and antibiofilm characteristics of synthesized zinc oxide nanoparticles.
Ebadi M; Zolfaghari MR; Aghaei SS; Zargar M; Noghabi KA
J Appl Microbiol; 2022 Jan; 132(1):221-236. PubMed ID: 34101961
[TBL] [Abstract][Full Text] [Related]
15. The powerful synergistic effect of spiramycin/propolis loaded chitosan/alginate nanoparticles on acute murine toxoplasmosis.
Hagras NA; Mogahed NMFH; Sheta E; Darwish AA; El-Hawary MA; Hamed MT; Elwakil BH
PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010268. PubMed ID: 35294434
[TBL] [Abstract][Full Text] [Related]
16. Enhanced anti-lung carcinoma and anti-biofilm activity of fungal molecules mediated biogenic zinc oxide nanoparticles conjugated with β-D-glucan from barley.
Saravanakumar K; Jeevithan E; Hu X; Chelliah R; Oh DH; Wang MH
J Photochem Photobiol B; 2020 Jan; 203():111728. PubMed ID: 31864088
[TBL] [Abstract][Full Text] [Related]
17. Green nanotechnology advances: green manufacturing of zinc nanoparticles, characterization, and foliar application on wheat and antibacterial characteristics using Mentha spicata (mint) and Ocimum basilicum (basil) leaf extracts.
Doğaroğlu ZG; Uysal Y; Çaylalı Z; Karakulak DS
Environ Sci Pollut Res Int; 2023 May; 30(21):60820-60837. PubMed ID: 37039921
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of novel arctigenin derivatives as potential anti-Toxoplasma gondii agents.
Zhang HB; Shen QK; Wang H; Jin C; Jin CM; Quan ZS
Eur J Med Chem; 2018 Oct; 158():414-427. PubMed ID: 30237124
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet, cytotoxic activities and characterization of green-synthesized zinc oxide nanoparticles using aqueous extract of Nephrolepis exaltata.
Aboul-Soud MAM; Siddique R; Fozia F; Ullah A; Rashid Y; Ahmad I; Zaghloul NSS; Al-Rejaie SS; Mohany M
Environ Sci Pollut Res Int; 2023 Jun; 30(29):73870-73880. PubMed ID: 37195603
[TBL] [Abstract][Full Text] [Related]
20. Remarkable histopathological improvement of experimental toxoplasmosis after receiving spiramycin-chitosan nanoparticles formulation.
Allam AF; Hagras NA; Farag HF; Osman MM; Shalaby TI; Kazem AH; Shehab AY; Mogahed NMFH
J Parasit Dis; 2022 Mar; 46(1):166-177. PubMed ID: 35299902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
